Research and Practice in Thrombosis and Haemostasis
短名 | Res Pract Thromb Haemost |
Journal Impact | 3.38 |
国际分区 | PERIPHERAL VASCULAR DISEASE(Q1) |
期刊索引 | SCI Q2中科院 3 区 |
ISSN | 2475-0379 |
h-index | 39 |
国内分区 | 医学(3区)医学血液学(3区)医学外周血管病(3区) |
涉及主题 | 医学内科学生物外科心理学精神科病理化学免疫学生物化学遗传学血小板血栓形成数学心脏病学统计 |
出版信息 | 出版商: Elsevier B.V.,出版周期: ,期刊类型: journal |
基本数据 | 创刊年份: 2017,原创研究文献占比: 88.37%,自引率:17.60%, Gold OA占比: 63.87% |
平均审稿周期 | 网友分享经验:7 Weeks |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Multiple myeloma: retrospective assessment of routine thromboprophylaxis and utility of thrombotic risk scores
2024-9-1
Impact of the VTE-PREDICT Calculator on Clinicians’ Decision-Making in Fictional Patients with Venous Thromboembolism A randomized controlled trial
2024-9-1
Platelet reactivity is associated with pump thrombosis in patients with left ventricular assist devices
2024-9-1
Predictors of Diagnostic Delays and Loss to Follow-up in Women with von Willebrand Disease: A Single-Centre Retrospective Cohort Study
2024-9-1
Fibrinaloid microclots in Long COVID: assessing the actual evidence properly
2024-9-1
Mathematical modeling identifies clotting factor combinations that modify thrombin generation in normal and factor VIII, IX, or XI deficient blood.
2024-9-1
Hyperfibrinolysis: A Crucial Phenotypic Abnormality of Post-traumatic Fibrinolytic Dysfunction
2024-9-1
Comorbidity and adverse events in acquired hemophilia A: data from the GTH-AHA-EMI study
2024-9-1
Dual Direct Oral Anticoagulant Therapy in Challenging Thrombosis: A Case Series
2024-8-1
Methods of a cluster-randomized, Type II hybrid implementation effectiveness trial to prospectively assess extended-duration thromboprophylaxis for at-risk discharging medical patients to prevent hospital-associated venous thromboembolism
2024-8-1
How to undertake procedures while on anti-platelet agents – a haematologist view
2024-8-1
Comprehensive literature review of protein C concentrate use in patients with severe congenital protein C deficiency
2024-8-1
Erratum to ‘Performance of Risk Scores in Predicting Major Bleeding in Left Ventricular Assist Device (LVAD) Recipients: a Comparative External Validation. ’[Res Pract Thromb Haemost. 2024;8:e102437]
2024-8-1
Pharmacokinetics and Pharmacodynamics of Low Doses of Recombinant Tissue Plasminogen Activator to establish a model for biosimilarity comparisons
2024-8-1
Evaluation of hemostasis understanding in medical and pharmacy students from a Parisian University
2024-8-1
Intensive Care Treatment in Acute Pulmonary Embolism in Germany, 2016 to 2020: A Nationwide Inpatient Database Study
2024-8-1
G Protein-coupled Receptor Kinase 5 regulates thrombin signaling in platelets
2024-8-1
Cross-reacting anti-porcine FVIII inhibitors in patients with acquired hemophilia A
2024-8-1
Fibrinolytic profile depends on disease severity in pediatric patients with cirrhosis: illustration by two different plasma-based fibrinolysis assays.
2024-8-1
Traumatic bleeding and mortality in mice are intensified by iron deficiency anemia and can be rescued with tranexamic acid
2024-8-1
Prescription and Switching Patterns of Direct Oral Anticoagulants in Patients With Atrial Fibrillation
2024-8-1
Anti-polyphosphate monoclonal antibodies derived from autoimmune mice
2024-8-1
PHYSICIAN PRACTICE PATTERNS ON THE USE OF INFERIOR VENA CAVA FILTERS IN VENOUS THROMBOEMBOLISM
2024-8-1
Plant-derived compounds normalise platelet bioenergetics and function in hyperglycaemia
2024-8-1
LAIR-1 and PECAM-1 function via the same signaling pathway to inhibition GPVI-mediated platelet activation
2024-8-1
A Single-center Study of Patients with Rare Isolated Acquired Clotting Factor Deficiencies Other than Acquired Hemophilia A
2024-8-1
MYH9-related inherited thrombocytopenia: the genetic spectrum, underlying mechanisms, clinical phenotypes, diagnosis and management approaches
2024-8-1
Proportion and risk factors for hospital-acquired venous thromboembolism in children: A systematic review and meta-analysis of data from 20 million individuals in 22 countries
2024-8-1
Oxidative stress-induced fibrinogen modifications in liver transplant recipients: unraveling a novel potential mechanism for cardiovascular risk
2024-8-1
Can hemophilia be cured? It depends on the definition
2024-8-1
Letter in response to Bounaix et al. “Management of anticoagulation and factor XIII replacement in a patient with severe factor XIII deficiency and recurrent venous thromboembolic disease: case report and review of literature”
2024-7-26
Primary Postpartum Hemorrhage in Women with von Willebrand Disease and Carriers of Hemophilia: A Retrospective Analysis
2024-7-1
Rivaroxaban for Stroke patients with Antiphospholipid Syndrome (RISAPS): protocol for a randomised controlled, phase IIb proof-of-principle trial
2024-7-1
Safety and efficacy of anticoagulant treatment in patients with ovarian vein thrombosis: a systematic review and meta-analysis of observational studies
2024-7-1
Erratum to ‘Illustrated State-of-the-Art Capsules of the ISTH 2024 Congress’ [Research and Practice in Thrombosis and Haemostasis Volume 8, Issue 4, May 2024, 102432]
2024-7-1
Low incidence of deep vein thrombosis in critically ill medical patients in Thais: a prospective study
2024-7-1
Exploratory rivaroxaban trial for isolated calf deep vein thrombosis with a risk factor of thrombosis extension: an open-label, multicenter, randomized controlled trial
2024-7-1
Thromboembolic events in severe postpartum haemorrhage treated with recombinant activated factor VII: a systematic literature review and meta-analysis
2024-7-1
Transmembrane thiol isomerase TMX1 counterbalances the effect of ERp46 to inhibit platelet activation and integrin αIIbβ3 function
2024-7-1
A machine learning model for early and accurate prediction of overt disseminated intravascular coagulation before its progression to an overt stage
2024-7-1
Is lupus anticoagulant testing with dilute Russell’s viper venom clotting times reliable in the presence of inflammation?
2024-7-1
A rare case of acquired von Willebrand syndrome type 2B: diagnosis, treatment, and underlying pathophysiology
2024-7-1
In vitro assessment of the risk of ABCB1-mediated drug–drug interaction between rivaroxaban and tacrolimus in human embryonic kidney 293 recombinant cell lines
2024-7-1
Managing Surgical Relapse Risk in Acquired Thrombotic Thrombocytopenic Purpura: A Systematic Review
2024-7-1
Hemorrhage in acute promyelocytic leukemia—fibrinolysis in focus
2024-7-1
Electronic consultation to improve care outcomes in patients with suspected and confirmed heparin-induced thrombocytopenia (HIT)
2024-7-1
Spontaneous Bleeding in Chronic Kidney Disease - Global Coagulation Assays May Predict Bleeding Risk
2024-7-1
Integrating musculoskeletal ultrasound as a shared decision-making tool in hemophilia care: observations from a 3-year study
2024-7-1
Excessive cleavage of von Willebrand factor multimers by ADAMTS13 may predict the progression of transplant-associated thrombotic microangiopathy
2024-7-1
The Association between Unemployment and Treatment Among Adults with Hemophilia
2024-7-1
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远